Targeting breast cancer in a surprising way
Nowadays there are quite a few compounds in clinical trials to assay their potential as breast cancer treatments. Some of them are the so called “PARP inhibitors”. These inhibitors work very well in tumours that have a deficiency in DNA repair because PARP proteins are involved in that process. However, a group of researchers working […]